Information1 | |
---|---|
Image | |
BRC No. | RBRC11436 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6.129S6-Islr<tm1.1(cre/ERT2)Mat> |
Former Common name | Meflin-CreERT2 |
H-2 Haplotype | |
ES Cell line | CSL3[129S6/SvEvTac] |
Background strain | |
Appearance | |
Strain development | Deposited by Atsushi Enomoto and Masahide Takahashi, Nagoya University in 2021. This strain was generated using CSL3 (ES cell) derived from 129S6/SvEvTac and mice were backcrossed to C57BL/6J for more than 8 generations. |
Strain description | Cre/ERT2 konckin mice in which an open reading frame of the Islr gene was replaced with Cre/ERT2. |
Colony maintenance | |
References | Cancer Res., 79(20):5367-5381 (2019). doi: 10.1158/0008-5472.CAN-19-0454. 31439548 |
Health Report | |
---|---|
Examination Date / Room / Rack | 2022/04/11Room:3-BRack:H |
Gene | |
---|---|
Gene info | Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Islrimmunoglobulin superfamily containing leucine-rich repeat9Islr<tm1.1(cre/ERT2)Mat>targeted mutation 1.1,Masahide TakahashiMeflin Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter ERT2estrogen receptor (ER), human ER with the triple mutation G400V/M543A/L544A)9ERT2 Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Frtyeast FRT (flippase recombination target) site9Frt Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter HBBhuman beta-globin polyA9HBB Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter crePhage P1 Cre recombinase9cre |
Information2 | |
---|---|
Donor DNA | P1 bacteriophage Cre, Human ERT2 cDNA, Human beta-globin polyA, Saccharomyces cerevisiae FRT site, Mouse Islr (knock-in)genomic DNA |
Research application | Cre/loxP system FLP/frt system |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Cancer Res. 2019 Oct 15;79(20):5367-5381. doi: 10.1158/0008-5472.CAN-19-0454.For use of the BIOLOGICAL RESOURCE by a for-profit organization, the RECIPIENT shall reach an agreement with the DEPOSITOR on terms and conditions of use of the BIOLOGICAL RESOURCE and shall obtain a prior written consent from the DEPOSITOR. The RECIPIENT must contact the DEPOSITOR in the case of application for an patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Atsushi Enomoto (Nagoya University) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |